Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Neural Tube Defects: A Retrospective Study of 69 Cases.

Turhan AH, Isik S.

Asian J Neurosurg. 2019 Apr-Jun;14(2):506-509. doi: 10.4103/ajns.AJNS_300_18.

2.

Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterations.

Griscelli F, Desterke C, Feraud O, Divers D, Oudrhiri N, Tosca L, Turhan AG, Bennaceur-Griscelli A.

Oncotarget. 2019 Apr 12;10(28):2693-2708. doi: 10.18632/oncotarget.26857. eCollection 2019 Apr 12.

3.

Global MicroRNA Profiling Uncovers miR-206 as a Negative Regulator of Hematopoietic Commitment in Human Pluripotent Stem Cells.

Flamant S, Chomel JC, Desterke C, Féraud O, Gobbo E, Mitjavila-Garcia MT, Foudi A, Griscelli F, Turhan AG, Bennaceur-Griscelli A.

Int J Mol Sci. 2019 Apr 8;20(7). pii: E1737. doi: 10.3390/ijms20071737.

4.

The effects of short-term use of granulocyte colony-stimulating factor on bone metabolism in child cancer patients.

Turhan AB, Binay C, Bor O, Simsek E.

North Clin Istanb. 2018 Dec 3;5(4):277-281. doi: 10.14744/nci.2017.59320. eCollection 2018.

5.

Modeling malignancies using induced pluripotent stem cells: from chronic myeloid leukemia to hereditary cancers.

Turhan A, Foudi A, Hwang JW, Desterke C, Griscelli F, Bennaceur-Griscelli A.

Exp Hematol. 2019 Mar;71:61-67. doi: 10.1016/j.exphem.2019.01.003. Epub 2019 Jan 16. Review.

PMID:
30659851
6.

Clinically silent indolent T-cell leukemia.

Janot C, Feriel J, Borie C, Lefevre E, Bennaceur-Griscelli A, Turhan AG, Aumont C.

Clin Case Rep. 2018 Nov 10;7(1):24-26. doi: 10.1002/ccr3.1528. eCollection 2019 Jan.

7.

A composite lymphoma combining a Hodgkin lymphoma and a marginal zone lymphoma transformed into a diffuse large B-cell lymphoma.

Auditeau C, Lambotte O, Feriel J, Lazure T, Turhan A, Aumont C.

Clin Case Rep. 2018 Oct 22;6(12):2341-2346. doi: 10.1002/ccr3.1841. eCollection 2018 Dec.

8.

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).

Gentil M, Hugues P, Desterke C, Telliam G, Sloma I, Souza LEB, Baykal S, Artus J, Griscelli F, Guerci A, Johnson-Ansah H, Foudi A, Bennaceur-Griscelli A, Turhan AG.

PLoS One. 2018 Aug 9;13(8):e0200923. doi: 10.1371/journal.pone.0200923. eCollection 2018.

9.

[NK cells: a major role in the antitumoral immunomodulation in CML].

Toubert A, Turhan A, Guerci-Bresler A, Dulphy N, Réa D.

Med Sci (Paris). 2018 Jun-Jul;34(6-7):540-546. doi: 10.1051/medsci/20183406013. Epub 2018 Jul 31. Review. French.

10.

Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy.

Sandt C, Feraud O, Bonnet ML, Desterke C, Khedhir R, Flamant S, Bailey CG, Rasko JEJ, Dumas P, Bennaceur-Griscelli A, Turhan AG.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1861-1867. doi: 10.1016/j.bbrc.2018.07.127. Epub 2018 Jul 26.

PMID:
30057314
11.

Effects of hypothermia on lung inflammation in a rat model of meconium aspiration syndrome.

Turhan AH, Atıcı A, Sürmeli S.

Acta Cir Bras. 2018 Jun;33(6):483-490. doi: 10.1590/s0102-865020180060000002.

12.

Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML).

Desterke C, Voldoire M, Bonnet ML, Sorel N, Pagliaro S, Rahban H, Bennaceur-Griscelli A, Cayssials E, Chomel JC, Turhan AG.

Exp Hematol. 2018 Aug;64:71-83.e8. doi: 10.1016/j.exphem.2018.04.007. Epub 2018 May 5.

PMID:
29733872
13.

Resolution enhancement of wide-field interferometric microscopy by coupled deep autoencoders.

Işil Ç, Yorulmaz M, Solmaz B, Turhan AB, Yurdakul C, Ünlü S, Ozbay E, Koç A.

Appl Opt. 2018 Apr 1;57(10):2545-2552. doi: 10.1364/AO.57.002545.

PMID:
29714238
14.

Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation.

Griscelli F, Ezanno H, Soubeyrand M, Feraud O, Oudrhiri N, Bonnefond A, Turhan AG, Froguel P, Bennaceur-Griscelli A.

Stem Cell Res. 2018 May;29:56-59. doi: 10.1016/j.scr.2018.02.017. Epub 2018 Mar 7.

15.

Superoxide dismutase 2 (SOD2) contributes to genetic stability of native and T315I-mutated BCR-ABL expressing leukemic cells.

Girerd S, Tosca L, Herault O, Vignon C, Biard D, Aggoune D, Dkhissi F, Bonnet ML, Sorel N, Desterke C, Bennaceur-Griscelli A, Tachdjian G, Guilhot F, Guilhot J, Chomel JC, Turhan AG.

Biochem Biophys Res Commun. 2018 Apr 15;498(4):715-722. doi: 10.1016/j.bbrc.2018.03.023. Epub 2018 Mar 17.

PMID:
29550484
16.

Evaluation of hypercoagulability with rotational thromboelastometry in children with iron deficiency anemia.

Özdemir ZC, Düzenli Kar Y, Gündüz E, Turhan AB, Bör Ö.

Hematology. 2018 Oct;23(9):664-668. doi: 10.1080/10245332.2018.1452456. Epub 2018 Mar 15.

PMID:
29544395
17.

Neurocognitive Consequences of Childhood Leukemia and Its Treatment.

Turhan AB, Tülin Fidan S, Yarar C, Nazlı Sakallı E, Özdemir ZC, Bör Ö.

Indian J Hematol Blood Transfus. 2018 Jan;34(1):62-69. doi: 10.1007/s12288-017-0846-4. Epub 2017 Jul 4.

18.

Corrigendum: Non integrative strategy decreases chromosome instability and improves endogenous pluripotency genes reactivation in porcine induced pluripotent-like stem cells.

Congras A, Barasc H, Canale-Tabet K, Plisson-Petit F, Delcros C, Feraud O, Oudrhiri N, Hadadi E, Griscelli F, Bennaceur-Griscelli A, Turhan A, Afanassieff M, Ferchaud S, Pinton A, Yerle-Bouissou M, Acloque H.

Sci Rep. 2018 Jan 8;8:46931. doi: 10.1038/srep46931.

19.

Transcriptional landscape of a RETC634Y-mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancers.

Hadoux J, Desterke C, Féraud O, Guibert M, De Rose RF, Opolon P, Divers D, Gobbo E, Griscelli F, Schlumberger M, Bennaceur-Griscelli A, Turhan AG.

Stem Cell Res. 2018 Jan;26:8-16. doi: 10.1016/j.scr.2017.11.015. Epub 2017 Nov 23.

20.

Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene.

Griscelli F, Oudrhiri N, Feraud O, Divers D, Portier L, Turhan AG, Bennaceur Griscelli A.

Stem Cell Res. 2017 Oct;24:135-138. doi: 10.1016/j.scr.2017.09.003. Epub 2017 Sep 14.

21.

Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutation.

Griscelli F, Feraud O, Ernault T, Oudrihri N, Turhan AG, Bonnefond A, Froguel P, Bennaceur-Griscelli A.

Stem Cell Res. 2017 Aug;23:178-181. doi: 10.1016/j.scr.2017.07.023. Epub 2017 Jul 25.

22.

Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation.

Bennaceur-Griscelli A, Hadoux J, Féraud O, Opolon P, Divers D, Gobbo E, Schlumberger M, Griscelli F, Turhan AG.

Stem Cell Res. 2017 Aug;23:154-157. doi: 10.1016/j.scr.2017.07.022. Epub 2017 Jul 22.

23.

Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).

Aggoune D, Sorel N, Bonnet ML, Goujon JM, Tarte K, Hérault O, Domenech J, Réa D, Legros L, Johnson-Ansa H, Rousselot P, Cayssials E, Guerci-Bresler A, Bennaceur-Griscelli A, Chomel JC, Turhan AG.

Leuk Res. 2017 Sep;60:94-102. doi: 10.1016/j.leukres.2017.07.007. Epub 2017 Jul 26.

PMID:
28772207
24.

Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.

Sloma I, Mitjavila-Garcia MT, Feraud O, Griscelli F, Oudrhiri N, El Marsafy S, Gobbo E, Divers D, Proust A, Smadja DM, Desterke C, Carles A, Ma Y, Hirst M, Marra MA, Eaves CJ, Bennaceur-Griscelli A, Turhan AG.

Exp Hematol. 2017 Sep;53:48-58. doi: 10.1016/j.exphem.2017.05.007. Epub 2017 Jun 8.

PMID:
28602946
25.

Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.

Chen M, Turhan AG, Ding H, Lin Q, Meng K, Jiang X.

Oncotarget. 2017 Jul 4;8(27):43662-43677. doi: 10.18632/oncotarget.18216.

26.

Is N-acetylcysteine infusion an effective treatment option in L-asparaginase associated hepatotoxicity?

Özdemir ZC, Turhan AB, Eren M, Bor Ö.

Blood Res. 2017 Mar;52(1):69-71. doi: 10.5045/br.2017.52.1.69. Epub 2017 Mar 27. No abstract available.

27.

Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.

Desbourdes L, Javary J, Charbonnier T, Ishac N, Bourgeais J, Iltis A, Chomel JC, Turhan A, Guilloton F, Tarte K, Demattei MV, Ducrocq E, Rouleux-Bonnin F, Gyan E, Hérault O, Domenech J.

Stem Cells Dev. 2017 May 15;26(10):709-722. doi: 10.1089/scd.2016.0295. Epub 2017 Apr 10.

28.

Generation of an induced pluripotent stem cell line from a patient with chronic myeloid leukemia (CML) resistant to targeted therapies.

Telliam G, Féraud O, Griscelli F, Opolon P, Divers D, Bennaceur-Griscelli A, Turhan AG.

Stem Cell Res. 2016 Sep;17(2):235-237. doi: 10.1016/j.scr.2016.08.001. Epub 2016 Aug 4.

29.

Congenital amegakaryocytic thrombocytopenia with severe neurological findings.

Bör Ö, Turhan AB, Yarar C.

Blood Coagul Fibrinolysis. 2016 Dec;27(8):936-939.

PMID:
27100302
30.

A school-based programme for tobacco and alcohol prevention in special education: effectiveness of the modified 'healthy school and drugs' intervention and moderation by school subtype.

Turhan A, Onrust SA, Ten Klooster PM, Pieterse ME.

Addiction. 2017 Mar;112(3):533-543. doi: 10.1111/add.13672. Epub 2016 Dec 8.

PMID:
27767230
31.

In vitro culture and phenotypic and molecular characterization of gastric stem cells from human stomach.

Garcia M, Chomel JC, Mustapha P, Tran CT, Garnier M, Paris I, Quellard N, Godet J, Cremniter J, Bennaceur-Griscelli A, Lecron JC, Turhan AG, Burucoa C, Bodet C.

Helicobacter. 2017 Apr;22(2). doi: 10.1111/hel.12351. Epub 2016 Sep 4.

PMID:
27592706
32.

Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation.

Hadoux J, Féraud O, Griscelli F, Opolon P, Divers D, Gobbo E, Schlumberger M, Bennaceur-Griscelli A, Turhan AG.

Stem Cell Res. 2016 Jul;17(1):154-157. doi: 10.1016/j.scr.2016.06.008. Epub 2016 Jun 27.

33.

Evaluation of hypercoagulability state in perinatal arterial ischemic stroke with rotation thromboelastometry.

Kocak O, Yarar C, Turhan AB, Akay OM, Carman KB, Yakut A.

Childs Nerv Syst. 2016 Dec;32(12):2395-2401. Epub 2016 Aug 11.

PMID:
27514779
34.

Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by imatinib in chronic myeloid leukemia.

Vatel O, Aumont C, Mathy V, Petit M, Feriel J, Sloma I, Bennaceur-Griscelli A, Turhan AG.

Leuk Lymphoma. 2017 Feb;58(2):473-474. Epub 2016 Jul 7. No abstract available.

PMID:
27389710
35.

Erythropoietin may attenuate lung inflammation in a rat model of meconium aspiration syndrome.

Turhan AH, Atici A, Muşlu N, Polat A, Sungur MA.

Exp Lung Res. 2016 May;42(4):199-204. doi: 10.1080/01902148.2016.1190424. Epub 2016 Jun 7.

PMID:
27266360
36.

Non integrative strategy decreases chromosome instability and improves endogenous pluripotency genes reactivation in porcine induced pluripotent-like stem cells.

Congras A, Barasc H, Canale-Tabet K, Plisson-Petit F, Delcros C, Feraud O, Oudrhiri N, Hadadi E, Griscelli F, Bennaceur-Griscelli A, Turhan A, Afanassieff M, Ferchaud S, Pinton A, Yerle-Bouissou M, Acloque H.

Sci Rep. 2016 Jun 1;6:27059. doi: 10.1038/srep27059. Erratum in: Sci Rep. 2018 Jan 08;8:46931.

37.

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation.

Chomel JC, Bonnet ML, Sorel N, Sloma I, Bennaceur-Griscelli A, Rea D, Legros L, Marfaing-Koka A, Bourhis JH, Ame S, Guerci-Bresler A, Rousselot P, Turhan AG.

Oncotarget. 2016 Jun 7;7(23):35293-301. doi: 10.18632/oncotarget.9182.

38.

Use of herbs or vitamin/mineral/nutrient supplements by pediatric oncology patients.

Turhan AB, Bör Ö.

Complement Ther Clin Pract. 2016 May;23:69-74. doi: 10.1016/j.ctcp.2016.03.009. Epub 2016 Mar 25.

PMID:
27157962
39.

Reversible skin telangiectasia induced by imatinib mesylate in chronic myeloid leukemia.

Turhan AG.

Leuk Lymphoma. 2016 Nov;57(11):2731-2. doi: 10.3109/10428194.2016.1163346. Epub 2016 Apr 14. No abstract available.

PMID:
27078524
40.

Treatment with propranolol for infantile hemangiomas: single-center experience.

Turhan AB, Bör Ö, Özdemir ZC.

J Cosmet Dermatol. 2016 Sep;15(3):296-302. doi: 10.1111/jocd.12220. Epub 2016 Apr 7.

PMID:
27061310
41.

Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study.

Pincez T, Guitton C, Gauthier F, de Lambert G, Picard V, Fénéant-Thibault M, Turhan A, Mohandas N, Tchernia G, Garçon L.

Blood. 2016 Mar 24;127(12):1616-8. doi: 10.1182/blood-2015-11-679357. Epub 2016 Jan 15. No abstract available.

42.

Accessory Nostril: A Rare Congenital Nasal Anomaly.

Gulasi S, Turhan AH, Celik Y, Atici A, Vayisoglu Y, Ünal M.

J Craniofac Surg. 2015 Oct;26(7):e602-3. doi: 10.1097/SCS.0000000000002048. Review.

PMID:
26468836
43.

An integrated prediction and optimization model of biogas production system at a wastewater treatment facility.

Akbaş H, Bilgen B, Turhan AM.

Bioresour Technol. 2015 Nov;196:566-76. doi: 10.1016/j.biortech.2015.08.017. Epub 2015 Aug 14.

PMID:
26295443
44.

The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia.

Dkhissi F, Aggoune D, Pontis J, Sorel N, Piccirilli N, LeCorf A, Guilhot F, Chomel JC, Ait-Si-Ali S, Turhan AG.

Exp Hematol. 2015 Sep;43(9):775-80. doi: 10.1016/j.exphem.2015.04.013. Epub 2015 Jun 26.

PMID:
26118501
45.

Comparison of selective head cooling therapy and whole body cooling therapy in newborns with hypoxic ischemic encephalopathy: short term results.

Atıcı A, Çelik Y, Gülaşı S, Turhan AH, Okuyaz Ç, Sungur MA.

Turk Pediatri Ars. 2015 Mar 1;50(1):27-36. doi: 10.5152/tpa.2015.2167. eCollection 2015 Mar.

46.

Reply to "Better method for evaluating a new laboratory test for syphilis".

Enders M, Gleich M, Mühlbacher A, Sakuldamrongpanich T, Turhan A, Sertöz R, Semprini S, Sambri V.

Clin Vaccine Immunol. 2015 May;22(5):607-8. doi: 10.1128/CVI.00109-15. No abstract available.

47.

Cerebro-retinal microangiopathy with calcifications and cysts due to recessive mutations in the CTC1 gene.

Bisserbe A, Tertian G, Buffet C, Turhan A, Lambotte O, Nasser G, Alvin P, Tardieu M, Riant F, Bergametti F, Tournier-Lasserve E, Denier C.

Rev Neurol (Paris). 2015 May;171(5):445-9. doi: 10.1016/j.neurol.2015.01.566. Epub 2015 Apr 2.

PMID:
25843205
48.

Investigation of West Nile virus among healthy blood donors in the western part of Turkey.

Biçeroğlu SU, Karatayli E, Bayram A, Turhan A, Değirmenci A, Aydinok Y, Bozdayi AM, Sertöz ŞR.

Turk J Med Sci. 2015;45(1):84-8.

PMID:
25790534
49.

Spontaneous regeneration capacity of controlled small bowel perforations: an experimental study in rats.

Pekel Ö, Hatipoglu S, Turhan AN, Hatipoglu F, Abdullayev R, Göksel S.

Ulus Travma Acil Cerrahi Derg. 2015 Jan;21(1):15-21. doi: 10.5505/tjtes.2015.31369.

50.

[Neglected ipsilateral simultaneous ruptures of patellar and quadriceps tendon].

Karahasanoğlu İ, Yoloğlu O, Kerimoğlu S, Turhan AU.

Eklem Hastalik Cerrahisi. 2015;26(1):49-51. doi: 10.5606/ehc.2015.11. Turkish.

Supplemental Content

Loading ...
Support Center